These data, along with the significant downregulation of TACSTD2 and the abnormal distribution of CLDN1 and OCLN in primary liver tissue from HCV-associated HCC patients, prompted us to further investigate the role of TACSTD2 in HCV infection. This evidence concerns the gene TACSTD2 and hepatocellular carcinoma.